HCPCS drug code · CMS crosswalk
Capecitabine J-Code / HCPCS Code
In short
Capecitabine is billed under HCPCS J8522 — Capecitabine, oral, 50 mg. One billing unit is 50 mg. CMS's crosswalk lists 23 Capecitabine NDCs under this code.
Reference
- J8522
- Capecitabine, oral, 50 mgBilling unit: 50 mg
- Labelers
- Accord Healthcare Inc; American Health Packaging; Ascend Laboratories, LLC; Aurobindo Pharma Usa, Inc.; BluePoint Laboratories; Cipla USA, Inc.; Dr. Reddy's Laboratories Inc.; Genentech, Inc.and 4 more
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Capecitabine units and claim line
Enter the dose given to get the J8522 units and the NDC line for the CMS-1500 and the 837P.
Enter the dose given to build the claim line.
Capecitabine NDCs and billing units
From CMS’s ASP NDC–HCPCS crosswalk, effective October 1, 2026 through December 31, 2026. Billing units per package are CMS’s figures for the code’s unit.
| NDC (11-digit) | HCPCS | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| 00004-1101-50 | J8522 | Genentech, Inc. | 120 | 1200 |
| 00093-7473-06 | J8522 | Teva Pharmaceuticals USA, Inc. | 60 | 180 |
| 00093-7474-89 | J8522 | Teva Pharmaceuticals USA, Inc. | 120 | 1200 |
| 16729-0072-12 | J8522 | Accord Healthcare Inc | 60 | 180 |
| 16729-0073-29 | J8522 | Accord Healthcare Inc | 120 | 1200 |
| 55111-0496-60 | J8522 | Dr. Reddy's Laboratories Inc. | 60 | 180 |
| 55111-0497-04 | J8522 | Dr. Reddy's Laboratories Inc. | 120 | 1200 |
| 59651-0204-60 | J8522 | Aurobindo Pharma Usa, Inc. | 60 | 180 |
| 59651-0205-08 | J8522 | Aurobindo Pharma Usa, Inc. | 120 | 1200 |
| 60687-0149-94 | J8522 | American Health Packaging | 20 | 200 |
| 67877-0458-60 | J8522 | Ascend Laboratories, LLC | 60 | 180 |
| 67877-0459-12 | J8522 | Ascend Laboratories, LLC | 120 | 1200 |
| 68001-0487-06 | J8522 | BluePoint Laboratories | 60 | 180 |
| 68001-0488-07 | J8522 | BluePoint Laboratories | 120 | 1200 |
| 68001-0643-06 | J8522 | BluePoint Laboratories | 60 | 180 |
| 68001-0644-07 | J8522 | BluePoint Laboratories | 120 | 1200 |
| 69097-0948-08 | J8522 | Cipla USA, Inc. | 120 | 1200 |
| 69097-0949-03 | J8522 | Cipla USA, Inc. | 60 | 180 |
| 70756-0815-60 | J8522 | Lifestar Pharma | 60 | 180 |
| 70756-0816-22 | J8522 | Lifestar Pharma | 120 | 1200 |
| 72205-0006-60 | J8522 | Novadoz Pharmaceuticals LLC | 60 | 180 |
| 72205-0007-92 | J8522 | Novadoz Pharmaceuticals LLC | 120 | 1200 |
| 82009-0112-12 | J8522 | Quallent Pharmaceuticals | 120 | 1200 |
Capecitabine: common questions
- What is the J-code for Capecitabine?
- Capecitabine is billed under HCPCS J8522 — Capecitabine, oral, 50 mg. One billing unit is 50 mg. CMS's crosswalk lists 23 Capecitabine NDCs under this code.
- How many J8522 billing units are in a package of Capecitabine?
- CMS lists 180 to 1,200 billing units per package, depending on the NDC, where one unit is 50 mg. Units to report are based on the dose given, not the package.
- Is J8522 a CPT code?
- No. J8522 is a HCPCS Level II code from CMS for the drug itself. Giving it, for example by injection or infusion, is usually reported with a separate CPT administration code.